Elon Musk's Wealth Hurts Nobody Except the Feelings of the Greedy
Jim Acosta Is Standing Vigil at the Kennedy Center Signage; The Press Shows...
Scott Jennings Hammers CNN Panel Over Elon Musk Trillionaire Status
An American 250 Story
FBI: Nevada Man Allegedly Pocketed $7.8M From Federal Grant, Then Laundered It Through...
Pakistan Confirms Iran Deal. Here's What Comes Next.
BREAKING: Trump Announces US-Iran Peace Deal Complete
12 Dead After Plane Crashes in Missouri
Trump Uses SAVE America Act As Leverage for Major Security Legislation
World-Famous Singer Oliver Tree Dies After Mid-Air Helicopter Collision
Sen. Mitch McConnell Hospitalized, Reason Unclear
Deported Four Times, Convicted Kidnapper and Sex Offender Sentenced to 4 Years After...
Trump Confirms That Iranian Peace Deal Will Proceed Despite Last-Minute Air Strikes
'You Will Not Escape': DOJ Warns Ghost Fleet Operators After Tanker Captain's Guilty...
Trump Endorses Mike Collins Ahead of Georgia Senate Run-Off
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos